Interaction of i.v. anaesthetic agents with 5-HT3 receptors

British Journal of Anaesthesia

Volumn 76, Issue 2, 1996, Pages 271-273

  Appadu, B L ^a   Lambert, D G ^a  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Anaesthetics i.v.; Model, neuroblastoma cells; Serotonin (5 hydroxytryptamine); Vomiting, antiemetics; Vomiting, nausea

Indexed keywords

ANESTHETIC AGENT; ETOMIDATE; KETAMINE; PROPOFOL; SEROTONIN 3 RECEPTOR; THIOPENTAL; TROPISETRON;

ANIMAL CELL; ANTIEMETIC ACTIVITY; ARTICLE; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL;

EID: 0030063363     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/76.2.271     Document Type: Article

References (23)

1. Lerman J. Surgical and patient factors involved in post-operative nausea and vomiting. British Journal of Anaesthesia 1992; 69 (Suppl. 1): 24S-32S.
2. 3 receptor, a serotonin-gated ion channel. Science 1991; 254: 432-437.
3. 3 receptors in rat brain using radioligand binding. Nature (London) 1987; 330: 746-748.
4. Miner WD, Sanger GJ. Inhibition of cisplatin-induced vomiting by 5-hydroxytryptamine m-receptor antagonism. British Journal of Pharmacology 1986; 88: 497-499.
5. 3 antagonist. Anesthesia and Analgesia 1991; 72: 751-755.
6. Carpenter DO. Neural mechanisms in emesis. Canadian Journal of Physiology and Pharmacology 1990; 68: 230-236.
7. McCollum JSC, Milligan KR, Dundee JW. The antiemetic action of propofol. Anaesthesia 1988; 43: 239-240.
8. Raftery S, Sherry E. Total intravenous anaesthesia with propofol and alfentanil protects against nausea and vomiting. Canadian Journal of Anaesthesia 1992; 39: 37-40.
9. Weir PM, Munro HM, Reynolds PI, Lewis IH, Wilton NCT. Propofol infusion and the incidence of emesis in pediatric outpatient strabismus surgery. Anesthesia and Analgesia 1993; 76: 760-764.
10. Borgeat A, Wider-Smith OHG, Saiah M, Rifat K. Subhypnotic doses of propofol possess direct antiemetic properties. Anesthesia and Analgesia 1992; 74: 539-541.
11. Appadu BL, Strange PG, Lambert DG. Does propofol interact with D, dopamine receptors? Anesthesia and Analgesia 1994; 79: 1191-1192.
12. 3 receptor-mediated electrical response in cultured mouse neuroblastoma cells. Neuropharmacology 1988; 27: 301-307.
13. 50) of an enzymatic reaction. Biochemical Pharmacology 1973; 22: 3099-3108.
14. 3 binding sites in rat brain cortical membranes. Biochemical Pharmacology 1989; 38: 1693-1695.
15. 3 recognition sites in membranes of N1E-115 neuroblastoma cells by radioligand binding. Molecular Pharmacology 1988; 33: 303-309.
16. Lummis SCR, Kilpatrick GJ, Martin IL. Characterization of 5-HT receptors in intact N1E-115 neuroblastoma cells. European Journal of Pharmacology (Molecular Pharmacology section) 1990; 189: 223-227.
17. 3 receptors in N1E-115 neuroblastoma cells. British Journal of Pharmacology 1994; 112: 541-546.
18. Van Hamme MJ, Ghoneim MM, Ambre JJ. Pharmacokinetics of etomidate, a new intravenous anesthetic. Anesthesiology 1978; 49: 274-277.
19. White PF, Ham J, Way WL, Trevor AJ. Pharmacology of ketamine isomers in surgical patients. Anesthesiology 1990; 52: 231-239.
20. Burch PG, Stanski DR. The role of metabolism and protein binding in thiopental anesthesia. Anesthesiology 1983; 58: 146-152.
21. Shafer A, Doze VA, Shafer SL, White PF. Pharmacokinetics and pharmacodynamics of propofol infusion during general anesthesia. Anesthesiology 1988; 69: 348-356.
22. Shyr MH, Tsai TH, Tan PPC, Chen CF, Chan SH. Concentration and regional distribution of propofol in brain and spinal-cord during propofol anesthesia in rats. Neuroscience Letters 1995; 184: 212-215.
23. 3 receptor of N1E-115 neuroblastoma cells. Naunyn-Schmiedebergs Archives of Pharmacology 1993; 347: 125-132.